Halozyme Therapeutics, Inc. · NASDAQ:HALO
Ramsay David A exercised options for 10,000 Halozyme Therapeutics, Inc. shares (Form 4)
Traded Jun 30, 2026 · Filed Jul 2, 2026
On Jun 30, 2026, Ramsay David A (EVP, PRESIDENT, DRUG DELIVERY) exercised options for 10,000 Halozyme Therapeutics, Inc. shares, leaving 4,592 shares. Filed Jul 2, 2026 (Form 4).
- Options exercised
- 10,000 shares
- Holding after
- 4,592 shares
- Trading plan
- No
- Role
- EVP, PRESIDENT, DRUG DELIVERY
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | Option exercise | 10,000 | 10,000 | Direct | |
| Jun 30, 2026 | Common Stock | Shares withheld for tax | 5,408 | US$78.27 | 4,592 | Direct |